IBM:NYSEInternational Business Machines Corporation Analysis
Data as of 2026-09-03 - not real-time
$231.70
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
International Business Machines Corporation is priced at $231.70 and its moving averages line up in bearish order, the shorter trailing the longer. The last 30 days have gained 12.6%. RSI sits at 46.9, which reads as neutral, and MACD momentum is bullish. The recent range runs from support at $227.40 up to resistance at $241.80.
Multiples put this in fair territory: 20.5 times earnings against the sector's 35.3. Analyst price targets sit 5.9% above the current price. The 2.92% dividend yield looks covered by current payout levels.
Risk scores 6 out of 10, which is elevated for this asset class. With 30-day volatility of 30.4%, a beta of 0.88 and a maximum drawdown of 37.5%, position sizing matters here. The wider market backdrop reads extreme greed at 94 on the fear-greed composite.
This one splits by horizon — hold in the near term, buy further out, at 4/10 long-term conviction.
Multiples put this in fair territory: 20.5 times earnings against the sector's 35.3. Analyst price targets sit 5.9% above the current price. The 2.92% dividend yield looks covered by current payout levels.
Risk scores 6 out of 10, which is elevated for this asset class. With 30-day volatility of 30.4%, a beta of 0.88 and a maximum drawdown of 37.5%, position sizing matters here. The wider market backdrop reads extreme greed at 94 on the fear-greed composite.
This one splits by horizon — hold in the near term, buy further out, at 4/10 long-term conviction.
Top Market Events
Securities Fraud Investigation Into International Business Machines Corporation IBM Announced – Shareholders Who Lost...IBM reports modest growth amid shifting client priorities, while focusing on AI and quantum computing investments to...Morningstar%2c Inc.1monInternational Business Machines Corporation IBM Securities Investigation Notice - Levi &...
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 1/10
Key Factors
- Short-term moving averages stacked below long-term ones
- Trading below the 200-day average of 262.99
- MACD momentum is positive
Medium Term
1–3 yearsNeutral
Model confidence: 2/10
Key Factors
- Short-term moving averages stacked below long-term ones
- P/E of 20.5 versus sector average of 35.3
- Trading below the 200-day average of 262.99
Long Term
> 3 yearsPositive
Model confidence: 4/10
Key Factors
- P/E of 20.5 versus sector average of 35.3
- Analyst targets imply +5.9% versus the current price
- Profit margin of 15.5% is healthy
Key Metrics & Analysis
Financial Health
Revenue Growth1.10%
Profit Margin15.52%
P/E Ratio20.5
ROE34.46%
ROA5.30%
Debt/Equity188.97
P/B Ratio6.3
Op. Cash Flow$14.9B
Free Cash Flow$12.0B
Industry P/E35.3
Technical Analysis
TrendBearish
RSI46.9
Support$227.40
Resistance$241.80
MA 20$234.37
MA 50$242.38
MA 200$262.99
MACDBullish
VolumeDecreasing
Fear & Greed Index94.29
Valuation
Fair Value$108.70
Target Price$245.35
Upside/Downside5.89%
GradeFair
TypeBlend
Dividend Yield2.92%
Risk Assessment
Beta0.88
Volatility30.38%
Sector RiskHigh
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.